share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Officer Sperzel John J III

SEC announcement ·  Feb 20 16:06
Summary by Moomoo AI
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 20, 2024, involving the acquisition of 160 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have increased to a total of 333 shares. The transaction reflects a continued investment in the company by an individual with a remarked relationship to the issuer.
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 20, 2024, involving the acquisition of 160 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have increased to a total of 333 shares. The transaction reflects a continued investment in the company by an individual with a remarked relationship to the issuer.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more